Company Overview
PAION is headquartered in Aachen, Germany and has a second site in Cambridge, UK. The company is specialised in developing innovative drugs for the hospital-based treatment in indications for which there is a substantial unmet medical need. PAION is extending its 'Search & Develop' business model, by transforming into a 'Specialty Pharma Company', with a focus on anaesthesia products.
PAION is listed at the Frankfurt Stock Exchange (General Standard Regulated Market, Stock Symbol PA8, ISIN DE000A0B65S3).